Clinical trial
A Retrospective Registry on the Use of CUSA® for the Treatment of Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminata
NCT06297187 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Registry on the Use of CUSA® for the Treatment of Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminata
- Lead sponsor
- Integra LifeSciences Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 23, 2024
- Completion date
- August 31, 2024
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
condylomata acuminata, vulvar intraepithelial neoplasia